Page last updated: 2024-08-26

2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine and Kahler Disease

2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine has been researched along with Kahler Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cabibbo, A; Ciapponi, L; Ciliberto, G; Klein, B; Lahm, A; Paonessa, G; Pulkki, K; Savino, R; Sporeno, E; Sun, RX; Toniatti, C1
Brochier, J; Gueydon, E; Jacquet, C; Klein, B; Rème, T1

Other Studies

2 other study(ies) available for 2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine and Kahler Disease

ArticleYear
Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells.
    Blood, 1996, Jun-01, Volume: 87, Issue:11

    Topics: Antigens, CD; Carcinoma, Hepatocellular; Growth Inhibitors; Humans; Interleukin-6; Liver Neoplasms; Melanoma; Models, Molecular; Morpholines; Multiple Myeloma; Neoplasm Proteins; Peptide Fragments; Polymerase Chain Reaction; Protein Conformation; Receptors, Interleukin; Receptors, Interleukin-6; Recombinant Fusion Proteins; Structure-Activity Relationship; Tumor Cells, Cultured

1996
Growth and immortalization of human myeloma cells in immunodeficient severe combined immunodeficiency mice: a preclinical model.
    British journal of haematology, 2001, Volume: 114, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Cell Division; Collagen; Drug Combinations; Endothelial Growth Factors; Female; Injections, Subcutaneous; Interleukin-6; Laminin; Lymphokines; Mice; Mice, SCID; Models, Animal; Morpholines; Multiple Myeloma; Proteoglycans; Recombinant Proteins; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2001